Literature DB >> 4805106

Are monoamine-oxidase inhibitors antidepressants?

T P Tyrer.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4805106      PMCID: PMC1645382     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  8 in total

1.  Differentiation of two genetically specific types of depression by the response to anti-depressants.

Authors:  C M PARE; L REES; M J SAINSBURY
Journal:  Lancet       Date:  1962-12-29       Impact factor: 79.321

2.  A clinical comparison of phenelzine and electro-convulsive therapy in the treatment of depressive illness.

Authors:  W J STANLEY; H FLEMING
Journal:  J Ment Sci       Date:  1962-09

3.  Phenelzine in phobic anxiety: a controlled trial.

Authors:  P Tyrer; J Candy; D Kelly
Journal:  Psychol Med       Date:  1973-02       Impact factor: 7.723

4.  An attempt at validation of traditional psychiatric syndromes by cluster analysis.

Authors:  B S Everitt; A J Gourlay; R E Kendell
Journal:  Br J Psychiatry       Date:  1971-10       Impact factor: 9.319

5.  Some contributions to the measurement of psychopathology.

Authors:  J L Fleiss; B J Gurland; J E Cooper
Journal:  Br J Psychiatry       Date:  1971-12       Impact factor: 9.319

6.  The classification of depression by numerical taxonomy.

Authors:  I Pilowsky; S Levine; D M Boulton
Journal:  Br J Psychiatry       Date:  1969-08       Impact factor: 9.319

7.  Classification of depressed patients: a cluster analysis derived grouping.

Authors:  E S Paykel
Journal:  Br J Psychiatry       Date:  1971-03       Impact factor: 9.319

8.  Phenelzine in phobic states.

Authors:  D Kelly
Journal:  Proc R Soc Med       Date:  1973-09
  8 in total
  2 in total

1.  Screening procedures in volunteers and patients.

Authors:  P J Tyrer
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.

Authors:  L Bucci
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.